1. Home
  2. FMS vs CG Comparison

FMS vs CG Comparison

Compare FMS & CG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • CG
  • Stock Information
  • Founded
  • FMS 1996
  • CG 1987
  • Country
  • FMS Germany
  • CG United States
  • Employees
  • FMS N/A
  • CG N/A
  • Industry
  • FMS Misc Health and Biotechnology Services
  • CG Investment Managers
  • Sector
  • FMS Health Care
  • CG Finance
  • Exchange
  • FMS Nasdaq
  • CG Nasdaq
  • Market Cap
  • FMS 14.4B
  • CG 15.9B
  • IPO Year
  • FMS 1996
  • CG 2012
  • Fundamental
  • Price
  • FMS $24.90
  • CG $43.59
  • Analyst Decision
  • FMS Hold
  • CG Buy
  • Analyst Count
  • FMS 1
  • CG 15
  • Target Price
  • FMS $25.00
  • CG $51.77
  • AVG Volume (30 Days)
  • FMS 327.2K
  • CG 3.1M
  • Earning Date
  • FMS 05-06-2025
  • CG 04-30-2025
  • Dividend Yield
  • FMS 2.55%
  • CG 3.22%
  • EPS Growth
  • FMS 7.65
  • CG N/A
  • EPS
  • FMS 1.89
  • CG 2.77
  • Revenue
  • FMS $20,018,541,263.00
  • CG $4,739,900,000.00
  • Revenue This Year
  • FMS $5.05
  • CG N/A
  • Revenue Next Year
  • FMS $3.90
  • CG $11.79
  • P/E Ratio
  • FMS $25.99
  • CG $15.71
  • Revenue Growth
  • FMS N/A
  • CG 95.78
  • 52 Week Low
  • FMS $17.93
  • CG $36.65
  • 52 Week High
  • FMS $25.25
  • CG $57.50
  • Technical
  • Relative Strength Index (RSI)
  • FMS 59.35
  • CG 43.29
  • Support Level
  • FMS $24.25
  • CG $41.79
  • Resistance Level
  • FMS $25.11
  • CG $46.86
  • Average True Range (ATR)
  • FMS 0.44
  • CG 1.75
  • MACD
  • FMS 0.06
  • CG 0.41
  • Stochastic Oscillator
  • FMS 90.14
  • CG 53.94

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

About CG The Carlyle Group Inc.

The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.

Share on Social Networks: